Epidemiologic Features of Vulvovaginal Candidiasis among Reproductive-Age Women in India
Table 2
Prevalence of observed clinical signs, reported symptoms, and diagnosis (positive predictive value) of vulvovaginal candidiasis, Mysore, India 2005-2006.
Vaginal sign observed or symptom reported
Prevalence ( clinical visits)
% prevalence (95% CI)**
Diagnosed with vulvovaginal candidiasis
% diagnosed with vulvovaginal candidiasis (95% CI)**
Pruritis reported
735
29.0 (26.8, 31.2)
132
17.8 (14.8, 20.8)
Discharge reported
782
31.0 (29.0, 32.9)
122
15.3 (12.5, 18.1)
Erythema observed
239
9.5 (8.2, 10.8)
61
24.8 (18.7, 30.8)
Discharge observed
894
35.4 (33.4, 37.5)
162
17.6 (14.9, 20.3)
None
887
35.1 (33.0, 37.2)
—
—
Any one
916
36.2 (34.3, 38.1)
—
—
Any two
492
19.5 (17.8, 21.1)
84
16.7 (13.3, 20.1)
Any three
182
7.2 (6.1, 8.3)
75
40.1 (33.7, 47.9)
All four
51
2.0 (1.4, 2.6)
21
40.9 (27.6, 54.2)
**Percentages and 95% confidence intervals calculated using generalized estimating equations, with binary family, identity link, and exchangeable correlation.
